pills-istock-525984851-1-1
sprng23 / iStockphoto.com
15 August 2018Americas

Purdue and Amneal OxyContin clash ends

A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
3 March 2017   Drugs company Purdue Pharma has filed a complaint against US-based generics company Amneal Pharmaceuticals for alleged patent infringement.
Americas
29 August 2018   Purdue Pharma has settled another patent dispute involving pain drug OxyContin (oxycodone), just weeks after a suit against generics company Amneal Pharmaceuticals came to an end.

More on this story

Americas
3 March 2017   Drugs company Purdue Pharma has filed a complaint against US-based generics company Amneal Pharmaceuticals for alleged patent infringement.
Americas
29 August 2018   Purdue Pharma has settled another patent dispute involving pain drug OxyContin (oxycodone), just weeks after a suit against generics company Amneal Pharmaceuticals came to an end.

More on this story

Americas
3 March 2017   Drugs company Purdue Pharma has filed a complaint against US-based generics company Amneal Pharmaceuticals for alleged patent infringement.
Americas
29 August 2018   Purdue Pharma has settled another patent dispute involving pain drug OxyContin (oxycodone), just weeks after a suit against generics company Amneal Pharmaceuticals came to an end.